In stage I non-small-cell lung cancer (NSCLC), but not in stage II, peritumoral but not intratumoral mast cell (tryptase+ chymase+) density was an independent favorable prognostic factor (111). The gene discussed is CMA1; the disease is non-small cell lung carcinoma.